Has Kent Kiracofe, MD received payments from drug or device companies?

Yes. Drug and device makers reported $188,505 in general payments to Kent Kiracofe, MD across 846 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kent Kiracofe, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kent Kiracofe, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kent Kiracofe, MD

Family Medicine · Manhattan, KSNPI 1285689380

Payments from drug & device makers

$188,505in general payments, 2019–2025

Across 846 payments — averaging $222.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

CSL Plasma Inc.$92K
CSL Behring$87K
Pfizer$1K
AbbVie$1K
Novo Nordisk$995
AstraZeneca$908
plus $5K from 42 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
CSL Plasma Inc.	122	$92,437
CSL Behring	121	$86,609
Pfizer	102	$1,362
AbbVie(2 entities)	88	$1,242
Novo Nordisk	70	$995
AstraZeneca	37	$908
Lilly USA, LLC	56	$795
Amgen	48	$577
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	20	$311
GSK	20	$305
Watermark Medical, Inc.	1	$299
Boehringer Ingelheim	19	$295
Takeda Pharmaceuticals U.S.A., Inc.	19	$265
Amarin Pharma, Inc.	11	$204
Johnson & Johnson	12	$179
Merck	11	$165
Jazz Pharmaceuticals Inc.	2	$162
Abbott	7	$135
Bayer	9	$127
Biohaven Pharmaceutical Holding Company Ltd.	12	$120
Astellas Pharma US Inc	6	$81
Sanofi-aventis U.S. LLC	6	$78
Teva Pharmaceuticals USA, Inc.	5	$69
Sumitomo Pharma America, Inc.	3	$68
Dexcom, Inc.	3	$63
Sanofi Pasteur Inc.	3	$62
Eisai Inc.	3	$59
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$55
Halozyme Inc	2	$41
Medtronic	1	$37
Novartis	2	$37
Radius Health, Inc.	3	$35
Corcept Therapeutics	2	$34
Esperion Therapeutics, Inc.	2	$33
Grifols USA, LLC	2	$32
Exact Sciences	2	$28
Biogen	1	$25
Axsome Therapeutics, Inc.	1	$24
Seqirus USA Inc	1	$20
Vanda Pharmaceuticals Inc.	1	$19
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$18
Antares Pharma, Inc.	1	$18
Idorsia Pharmaceuticals US Inc	1	$16
Shire North American Group Inc	1	$13
E.r. Squibb & Sons, L.L.C.	1	$13
Biohaven Pharmaceuticals, Inc.	1	$13
Regeneron Healthcare Solutions, Inc.	1	$12
Kowa Pharmaceuticals America, Inc.	1	$12

How this compares

$188,505 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas →

Medicare billing

Part B allowed, 2024

$204,531

Medicare patients

312

Services billed

13,748

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Manhattan

Bradley HarrisonManhattan$314K
Kyle PlatzManhattan$51K
Terry PolingWichita$24.2M
Richard GloverNewton$19.6M
Daniel DickersonLenexa$13.6M
Patrick YaoOlathe$11.7M
Michael RauschAugusta$8.1M
Terry KleinWichita$5.9M
Richard EgelhofWichita$4.1M
Thomas KleinWichita$3.4M

See the full list for Kansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →